Health Care & Life Sciences » Pharmaceuticals | Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
50.18 M
Public Float
35.64 M
Ultragenyx Pharmaceutical Inc.
Stock Exchange NASDAQ Stock Market
EPS
$6.35
Market Cap
$3.42 B
Shares Outstanding
57.47 M
Public Float
51.09 M

Profile

Address
60 Leveroni Court
Novato California 94949
United States
Employees -
Website http://www.ultragenyx.com
Updated 07/08/2019
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. The company was founded by Emil D.

Financials

View All

Emil D. Kakkis
President, Chief Executive Officer & Director
Daniel G. Welch
Non-Executive Chairman